The 2011 update to guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006, has been published by The Heart Foundation and the Cardiac Society of Australia and New Zealand, and is now available in the latest issue of the Medical Journal of Australia.
The update reflects new evidence relating to the use of B-type natriuretic peptide (BNP), including plasma-BNP or N-terminal, pro-BNP measurement in guiding treatment of chronic heart failure, physical activity and rehabilitation, pharmaco-therapy, the use of polyunsaturated fatty acids in the treatment of systolic heart failure, the use of devices such as biventricular pacing and left ventricular assist devices and the treatment of cardiac arrhythmias in patients with chronic heart failure.
MJA 2011; 194 (8): 405-409. Please contact your library if you have trouble accessing the full text of this article.
No comments:
Post a Comment